Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis Miguel QuintanaPaul Hjemdahlfor the ATTACC investigators Clinical Trials 18 March 2003 Pages: 1 - 9
Effects of fluticasone plus salmeterol versus twice the dose of fluticasone in asthmatic patients Graeme P. CurrieCaroline E. BatesBrian J. Lipworth Pharmacodynamics 22 March 2003 Pages: 11 - 15
A comparison of the pharmacokinetics of two dosing regimens of cisapride and their effects on corrected QT interval in premature infants Filip CoolsAvram BenatarYvan Vandenplas Pharmacodynamics 01 April 2003 Pages: 17 - 22
Quinine 3-hydroxylation as a biomarker reaction for the activity of CYP3A4 in man Rajaa A. MirghaniÖrjan EricssonLeif Bertilsson Pharmacodynamics and Disposition 11 March 2003 Pages: 23 - 28
Cytochrome P4502E1 (CYP2E1) expression in peripheral blood lymphocytes: evaluation in hepatitis C and diabetes Vincent HaufroidDanuta LigockaDominique Lison Pharmacokinetics and Disposition 22 March 2003 Pages: 29 - 33
Pharmacokinetics and pharmacodynamics of ximelagatran, a novel oral direct thrombin inhibitor, in young healthy male subjects Ulf G. ErikssonUlf BredbergDavid Gustafsson Pharmacokinetics and Disposition 27 March 2003 Pages: 35 - 43
Thioridazine steady-state plasma concentrations are influenced by tobacco smoking and CYP2D6, but not by the CYP2C9 genotype Roland BereczAlfredo de la RubiaAdrián LLerena Pharmacokinetics and Disposition 28 March 2003 Pages: 45 - 50
The effect of erythromycin on the pharmacokinetics of rosuvastatin K. J. CooperP. D. MartinD. W. Schneck Pharmacokinetics and Disposition 01 April 2003 Pages: 51 - 56
Polymorphic drug metabolism (CYP2D6) and utilisation of psychotropic drugs in hospitalised psychiatric patients: a retrospective study Wim J. TammingaJohan WemerJan H. G. Jonkman Pharmacoepidemiology and Prescription 18 March 2003 Pages: 57 - 64
Pharmacotherapeutic interventions by a multi-speciality team: opinions of the general practitioners and nurses Åsa BondessonPatrik MidlövPeter Höglund Pharmacoepidemiology and Prescription 01 April 2003 Pages: 65 - 69
Drug use for non-hepatic associated conditions in patients with liver cirrhosis M. Isabel LucenaRaúl J. Andradethe Spanish Collaborative Study Group on Therapeutic Management in Liver Diseases Pharmacoepidemiology and Prescription 09 April 2003 Pages: 71 - 76
EACPT 2001 in Odense was a success: now we are heading to Istanbul Folke Sjöqvist Conference Report 18 April 2003 Pages: 77 - 78
Efficacy, safety and cost of new drugs acting on the central nervous system Silvio GarattiniVittorio Bertele' Point of View 22 March 2003 Pages: 79 - 84
B. Lerer (ed): Pharmacogenetics of psychotropic drugs Cüneyt GüzeyOlav Spigset Book Review 10 April 2003 Pages: 85 - 85